Autor: |
Kiyoshi Yoshino, Takeshi Yokoi, Ruriko Nakae, Tadashi Kimura, Masami Fujita, Masahiko Takemura, Shoji Kamiura, Tateki Tsutsui, Takuji Tomimatsu, Kazushige Adachi, Eiji Kobayashi, Seiji Mabuchi, Kenjiro Sawada, Yasuhiko Shiki, Yutaka Ueda, Kae Hashimoto, A. Wakimoto, Takamichi Nishizaki, Yuki Kanda |
Rok vydání: |
2017 |
Předmět: |
|
Zdroj: |
Cancer Chemotherapy and Pharmacology. 80:1239-1247 |
ISSN: |
1432-0843 0344-5704 |
Popis: |
To develop a new therapeutic strategy for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancers, we evaluated the feasibility and efficacy of irinotecan and gemcitabine combination chemotherapy.Patients with taxane/platinum-resistant/refractory cancer received escalating doses of irinotecan and gemcitabine (level 1: 80 and 800 mg/mA total of 35 patients were enrolled. The recommended dose was defined as 100 mg/mCombination chemotherapy with irinotecan and gemcitabine represents a safe and effective treatment combination for taxane/platinum-resistant/refractory ovarian and primary peritoneal cancers. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|